ANI Pharmaceuticals Inc (ANIP)
Debt-to-assets ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — |
Total assets | US$ in thousands | 1,283,700 | 904,422 | 760,087 | 771,598 | 461,190 |
Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,283,700K
= 0.00
The debt-to-assets ratio for ANI Pharmaceuticals Inc has consistently been 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has no debt relative to its total assets across these years. A low or zero debt-to-assets ratio is generally considered favorable as it suggests that the company is not highly leveraged and has a lower risk of financial distress. ANI Pharmaceuticals Inc's consistent low debt-to-assets ratio reflects a strong financial position and stability in managing its debt levels relative to its asset base.
Peer comparison
Dec 31, 2024
Company name
Symbol
Debt-to-assets ratio
ANI Pharmaceuticals Inc
ANIP
0.00
Abbott Laboratories
ABT
0.00
AbbVie Inc
ABBV
0.00
ACADIA Pharmaceuticals Inc
ACAD
0.00
Alkermes Plc
ALKS
0.00
Amphastar P
AMPH
0.39
Arcus Biosciences Inc
RCUS
0.00
Biomarin Pharmaceutical Inc
BMRN
0.09
Bristol-Myers Squibb Company
BMY
0.51
Catalyst Pharmaceuticals Inc
CPRX
0.00
Collegium Pharmaceutical Inc
COLL
0.00